Catalyst Pharmaceuticals, Inc. (DELISTED) (CPRX:DL)
31.49
0.00 (0.00%)
USD |
NASDAQ |
Jul 24, 16:00
Catalyst Pharmaceuticals Total Liabilities (Quarterly) : 134.91M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 134.91M |
| December 31, 2025 | 152.54M |
| September 30, 2025 | 131.36M |
| June 30, 2025 | 115.89M |
| March 31, 2025 | 114.59M |
| December 31, 2024 | 126.86M |
| September 30, 2024 | 111.07M |
| June 30, 2024 | 97.70M |
| March 31, 2024 | 85.26M |
| December 31, 2023 | 84.03M |
| September 30, 2023 | 64.66M |
| June 30, 2023 | 68.60M |
| March 31, 2023 | 73.57M |
| December 31, 2022 | 76.55M |
| September 30, 2022 | 63.07M |
| June 30, 2022 | 26.22M |
| March 31, 2022 | 26.75M |
| December 31, 2021 | 30.96M |
| September 30, 2021 | 24.59M |
| June 30, 2021 | 20.19M |
| March 31, 2021 | 18.56M |
| December 31, 2020 | 22.76M |
| September 30, 2020 | 18.23M |
| June 30, 2020 | 20.21M |
| March 31, 2020 | 18.20M |
| Date | Value |
|---|---|
| December 31, 2019 | 24.75M |
| September 30, 2019 | 18.71M |
| June 30, 2019 | 14.95M |
| March 31, 2019 | 9.901M |
| December 31, 2018 | 9.666M |
| September 30, 2018 | 3.633M |
| June 30, 2018 | 3.225M |
| March 31, 2018 | 2.882M |
| December 31, 2017 | 4.424M |
| September 30, 2017 | 2.902M |
| June 30, 2017 | 2.011M |
| March 31, 2017 | 2.601M |
| December 31, 2016 | 2.398M |
| September 30, 2016 | 2.410M |
| June 30, 2016 | 2.616M |
| March 31, 2016 | 3.129M |
| December 31, 2015 | 4.625M |
| September 30, 2015 | 3.913M |
| June 30, 2015 | 5.545M |
| March 31, 2015 | 9.428M |
| December 31, 2014 | 8.666M |
| September 30, 2014 | 9.222M |
| June 30, 2014 | 4.741M |
| March 31, 2014 | 4.591M |
| December 31, 2013 | 3.978M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Inovio Pharmaceuticals, Inc. | 45.02M |
| Indivior Pharmaceuticals, Inc. | 1.441B |
| Exelixis, Inc. | 650.47M |
| United Therapeutics Corp. | 819.80M |
| Krystal Biotech, Inc. | 141.52M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.148B |
| Shareholders Equity (Quarterly) | 1.013B |
| Debt to Equity Ratio | 0.0026 |
| Current Ratio | 7.103 |
| Net Debt Paydown Yield | 0.00% |